(Q44491452)

3 December 2017

title

Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex (English)

1 reference

3 December 2017

0 references

Anne-Véronique Sambo

1 reference

3 December 2017

Malika Hamdane

1 reference

3 December 2017

Patrice Delobel

1 reference

3 December 2017

Séverine Bégard

1 reference

3 December 2017

Anne Violleau

1 reference

3 December 2017

André Delacourte

1 reference

3 December 2017

Philippe Bertrand

1 reference

3 December 2017

Jesus Benavides

1 reference

3 December 2017

Luc Buée

1 reference

3 December 2017

language of work or name

English

0 references

publication date

24 June 2003

1 reference

Journal of Biological Chemistry

3 December 2017

1 reference

inferred from page(s)

published in

1 reference

3 December 2017

volume

278

1 reference

3 December 2017

1 reference

3 December 2017

page(s)

34026-34034

1 reference

Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Mitotic mechanisms in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Phosphorylation Sites on Tau Identified by Nanoelectrospray Mass Spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Neurotoxicity induces cleavage of p35 to p25 by calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Modelling Alzheimer-specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Specificity and mechanism of action of some commonly used protein kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Regulation of expression, phosphorylation and biological activity of tau during differentiation in SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Alpha-synuclein expression is up-regulated in NTera2 cells during neuronal differentiation but unaffected by exposure to cytokines and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Cell cycle markers in the hippocampus in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Cdk5 is a key factor in tau aggregation and tangle formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Pin1: a therapeutic target in Alzheimer neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

Processing of cdk5 Activator p35 to Its Truncated Form (p25) by Calpain in Acutely Injured Neuronal Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M302872200

21 January 2018

Identifiers

DOI

10.1074/JBC.M302872200

1 reference

3 December 2017

1 reference